Literature DB >> 7866001

[Preliminary screening of Chinese herbal medicine in inhibiting Helicobacter pylori].

X L Wang1, W L Jiao, Z S Lu.   

Abstract

At present Helicobacter pylori (HP) was taken to be closely related to chronic atrophic gastritis and peptic ulcer. 226 patients with symptoms of upper digestive tract by endoscope were examined and chronic atrophic gastritis and peptic ulcer were diagnosed. Mucous membrane from gastric antrum was taken and cultured, and found that 136 cases of 226 patients were HP positive and the rate of positiveness was 60.18%. 200 kinds of Chinese herbal medicine were selected to investigate its inhibitory action on HP. Results indicated that 38 among 200 kinds of Chinese herbal medicine had inhibitory effects on HP, which provided evidence for diagnosis and treatment of chronic atrophic gastritis and peptic ulcer, also for inhibition of HP growth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7866001

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  4 in total

Review 1.  Innovative Perspectives of Integrated Chinese Medicine on H. pylori.

Authors:  Hui Ye; Zong-Ming Shi; Yao Chen; Jing Yu; Xue-Zhi Zhang
Journal:  Chin J Integr Med       Date:  2018-06-08       Impact factor: 1.978

2.  [Study of total alkaloids from Rhizoma Coptis Chinensis on experimental gastric ulcers].

Authors:  Bei Li; Jing-chuan Shang; Qi-xin Zhou
Journal:  Chin J Integr Med       Date:  2005-09       Impact factor: 1.978

3.  A randomized, multicenter and noninferiority study of amoxicillin plus berberine vs tetracycline plus furazolidone in quadruple therapy for Helicobacter pylori rescue treatment.

Authors:  Jian Zhang; Chuan Han; Wen Quan Lu; Na Wang; Si Ran Wu; Yong Xi Wang; Jin Ping Ma; Jie Hong Wang; Cheng Hao; Dong Hong Yuan; Na Liu; Yong Quan Shi
Journal:  J Dig Dis       Date:  2020-06-09       Impact factor: 2.325

4.  Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Xiaotao Jiang; Chenguang Jiang; Cihui Huang; Guoming Chen; Kailin Jiang; Baoyi Huang; Fengbin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-04       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.